Tenet Healthcare (NYSE:THC) Price Target Cut to $210.00 by Analysts at Robert W. Baird

Key Points

• Robert W. Baird cut its price target on Tenet Healthcare from $245 to $210 and maintained a "neutral" rating, implying roughly a 13.4% upside from the prior close.
• Tenet beat quarterly EPS estimates with EPS $4.82 vs. $4.21 and set FY2026 guidance of 16.38–18.68 EPS (consensus ~17.42), although revenue of $5.37B was slightly below expectations.
• Analyst sentiment remains positive overall, with 19 Buy and 3 Hold ratings and a consensus Moderate Buy average price target of $244.16.

Tenet Healthcare (NYSE:THC - Get Free Report) had its target price reduced by equities researchers at Robert W. Baird from $245.00 to $210.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has a "neutral" rating on the stock. Robert W. Baird's price objective suggests a potential upside of 13.36% from the stock's previous close.

Several other analysts also recently commented on THC. KeyCorp cut their price objective on shares of Tenet Healthcare from $250.00 to $225.00 and set an "overweight" rating on the stock in a research report on Friday. UBS Group increased their price objective on shares of Tenet Healthcare from $260.00 to $288.00 and gave the company a "buy" rating in a research report on Thursday, February 12th. Barclays reissued an "overweight" rating and set a $238.00 price objective on shares of Tenet Healthcare in a research report on Tuesday. Mizuho increased their price objective on shares of Tenet Healthcare from $235.00 to $265.00 and gave the company an "outperform" rating in a research report on Thursday, March 12th. Finally, Leerink Partners increased their price objective on shares of Tenet Healthcare from $255.00 to $264.00 and gave the company an "outperform" rating in a research report on Friday, February 20th. Nineteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $244.16.

Tenet Healthcare Stock Up 1.1%

Shares of Tenet Healthcare stock opened at $185.24 on Tuesday. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. The company has a 50-day moving average of $207.31 and a 200 day moving average of $204.33. The firm has a market cap of $16.23 billion, a price-to-earnings ratio of 9.63, a PEG ratio of 1.37 and a beta of 1.30. Tenet Healthcare has a 1 year low of $146.31 and a 1 year high of $247.21.

Tenet Healthcare (NYSE:THC - Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.21 by $0.61. The company had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. Tenet Healthcare's quarterly revenue was up 2.6% compared to the same quarter last year. During the same period last year, the business earned $4.36 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, sell-side analysts anticipate that Tenet Healthcare will post 17.42 earnings per share for the current fiscal year.

Insider Activity

In other news, insider R. Scott Ramsey sold 8,017 shares of the firm's stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $232.70, for a total transaction of $1,865,555.90. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Thomas W. Arnst sold 8,000 shares of the firm's stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $238.85, for a total transaction of $1,910,800.00. Following the sale, the executive vice president directly owned 12 shares in the company, valued at approximately $2,866.20. The trade was a 99.85% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 46,517 shares of company stock valued at $10,943,111 in the last 90 days. 0.81% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Tenet Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in THC. NewEdge Advisors LLC boosted its holdings in shares of Tenet Healthcare by 6.1% in the first quarter. NewEdge Advisors LLC now owns 2,890 shares of the company's stock worth $389,000 after buying an additional 166 shares during the last quarter. Jones Financial Companies Lllp boosted its holdings in shares of Tenet Healthcare by 299.1% in the first quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company's stock worth $229,000 after buying an additional 1,274 shares during the last quarter. Sivia Capital Partners LLC purchased a new position in shares of Tenet Healthcare in the second quarter worth approximately $290,000. Quantbot Technologies LP purchased a new position in shares of Tenet Healthcare in the second quarter worth approximately $65,000. Finally, Amundi boosted its holdings in shares of Tenet Healthcare by 4,207.8% in the second quarter. Amundi now owns 27,010 shares of the company's stock worth $4,652,000 after buying an additional 26,383 shares during the last quarter. Hedge funds and other institutional investors own 95.44% of the company's stock.

About Tenet Healthcare

Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.